<sentence id="0">Characterization of the ETSA-21 antigen , a glycosylphosphatidyl-inositol anchor glycoprotein identified in breast cancer cells using monoclonal antibody B21 .</sentence>
<sentence id="1">Mab B21 is a monoclonal antibody ( Mab ) that recognizes an epithelial tumor surface antigen ( ETSA-B21 ) from diverse human tumor cell lines including breast , ovary , uterus , and their cognate carcinoma tissues .</sentence>
<sentence id="2">A lower reactivity has been observed in normal breast tissue and benign hyperplesia .</sentence>
<sentence id="3">In this study , the characteristics of the ETSA-B21 antigen have been examined in greater detail in the MCF-7 , SK-BR-3 , and MDA-MB-453 breast cancer cell lines .</sentence>
<sentence id="4">Treatment with phosphatidylinositol-phospholipase C , but no neuraminidase were found to partially remove the ETSA-B21 signal from the cell surface as revealed by immunofluorescence microscopy .</sentence>
<sentence id="5">Inhibition of the N-glycosylation pathway by tunicamycin resulted in a decreased ETSA-B21 signal on the cell membrane .</sentence>
<sentence id="6">In addition , the antigen-antibody complex was internalized in breast cancer cells as demonstrated by an acidic was internalization assay evaluated using immunofluorescence .</sentence>
<sentence id="7">In conclusion , this study <scope type="spec" id="0"> <cue type="spec" id="0">suggests</cue> that ETSA-B21 is a GPI anchor N-glycosylated protein promoting specific antibody internalization in breast cancer cells</scope> .</sentence>